Cancer Immunology
- 19 June 2008
- journal article
- review article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 358 (25), 2704-2715
- https://doi.org/10.1056/nejmra072739
Abstract
This review is a comprehensive account of the current status of tumor immunology, beginning with the identification of human tumor antigens and ending with a summary of clinical applications of what we know about the immunology of tumors.Keywords
This publication has 99 references indexed in Scilit:
- Adoptive T cell therapy for cancer in the clinicJCI Insight, 2007
- Immunosuppressive Strategies that are Mediated by Tumor CellsAnnual Review of Immunology, 2007
- CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinomaProceedings of the National Academy of Sciences of the United States of America, 2007
- Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II studyBritish Journal of Cancer, 2006
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Checkpoint Blockade in Cancer ImmunotherapyAdvances in Immunology, 2006
- Regulatory T cells, tumour immunity and immunotherapyNature Reviews Immunology, 2006
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerThe New England Journal of Medicine, 2005
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002